CYNTHIA JOHNSON: Open Payments
NPI 1023555638 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 8 payments from 6 companies in 2025. Trend: 2023 $140 · 2024 $125 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Alkermes, Inc. | 1 | $14 |
Products named: COBENFY, FANAPT, REBLOZYL, VRAYLAR, REXULTI, CAPLYTA, LYBALVI.
Industry payments across IA — which companies pay providers there.
